Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction MW Johnson, A Garcia-Romeu, MP Cosimano, RR Griffiths Journal of psychopharmacology 28 (11), 983-992, 2014 | 989 | 2014 |
Long-term follow-up of psilocybin-facilitated smoking cessation MW Johnson, A Garcia-Romeu, RR Griffiths The American journal of drug and alcohol abuse 43 (1), 55-60, 2017 | 638 | 2017 |
Psilocybin-occasioned mystical experiences in the treatment of tobacco addiction A Garcia-Romeu, R R Griffiths, M W Johnson Current drug abuse reviews 7 (3), 157-164, 2014 | 521 | 2014 |
Psychedelic therapy for smoking cessation: Qualitative analysis of participant accounts T Noorani, A Garcia-Romeu, TC Swift, RR Griffiths, MW Johnson Journal of Psychopharmacology 32 (7), 756-769, 2018 | 244 | 2018 |
Cessation and reduction in alcohol consumption and misuse after psychedelic use A Garcia-Romeu, AK Davis, F Erowid, E Erowid, RR Griffiths, ... Journal of Psychopharmacology 33 (9), 1088-1101, 2019 | 224 | 2019 |
Clinical applications of hallucinogens: A review. A Garcia-Romeu, B Kersgaard, PH Addy Experimental and clinical psychopharmacology 24 (4), 229, 2016 | 203 | 2016 |
Current perspectives on psychedelic therapy: use of serotonergic hallucinogens in clinical interventions A Garcia-Romeu, WA Richards International Review of Psychiatry 30 (4), 291-316, 2018 | 175 | 2018 |
Self-transcendence as a measurable transpersonal construct A Garcia-Romeu Journal of Transpersonal Psychology 42 (1), 26, 2010 | 156 | 2010 |
Kratom (Mitragyna speciosa): User demographics, use patterns, and implications for the opioid epidemic A Garcia-Romeu, DJ Cox, KE Smith, KE Dunn, RR Griffiths Drug and alcohol dependence 208, 107849, 2020 | 132 | 2020 |
An online survey of tobacco smoking cessation associated with naturalistic psychedelic use MW Johnson, A Garcia-Romeu, PS Johnson, RR Griffiths Journal of psychopharmacology 31 (7), 841-850, 2017 | 127 | 2017 |
Exploring an intensive meditation intervention for incarcerated youth ES Barnert, S Himelstein, S Herbert, A Garcia‐Romeu, LJ Chamberlain Child and Adolescent Mental Health 19 (1), 69-73, 2014 | 116 | 2014 |
Persisting reductions in cannabis, opioid, and stimulant misuse after naturalistic psychedelic use: An online survey A Garcia-Romeu, AK Davis, E Erowid, F Erowid, RR Griffiths, ... Frontiers in psychiatry 10, 955, 2020 | 110 | 2020 |
Does mindfulness meditation increase effectiveness of substance abuse treatment with incarcerated youth? A pilot randomized controlled trial S Himelstein, S Saul, A Garcia-Romeu Mindfulness 6, 1472-1480, 2015 | 95 | 2015 |
Recent progress in Lyme disease and remaining challenges JR Bobe, BL Jutras, EJ Horn, ME Embers, A Bailey, RL Moritz, Y Zhang, ... Frontiers in medicine 8, 666554, 2021 | 94 | 2021 |
Set and setting: a randomized study of different musical genres in supporting psychedelic therapy JC Strickland, A Garcia-Romeu, MW Johnson ACS Pharmacology & Translational Science 4 (2), 472-478, 2020 | 70 | 2020 |
Self-transcendent experience: A grounded theory study A Garcia-Romeu, SP Himelstein, J Kaminker Qualitative Research 15 (5), 633-654, 2015 | 66 | 2015 |
Optimal dosing for psilocybin pharmacotherapy: Considering weight-adjusted and fixed dosing approaches A Garcia-Romeu, FS Barrett, TM Carbonaro, MW Johnson, RR Griffiths Journal of Psychopharmacology 35 (4), 353-361, 2021 | 63 | 2021 |
Understanding kratom use: a guide for healthcare providers MT Swogger, KE Smith, A Garcia-Romeu, O Grundmann, CA Veltri, ... Frontiers in pharmacology 13, 801855, 2022 | 55 | 2022 |
The subjective experience of acute, experimentally-induced Salvia divinorum inebriation PH Addy, A Garcia-Romeu, M Metzger, J Wade Journal of Psychopharmacology 29 (4), 426-435, 2015 | 48 | 2015 |
Whitewashing psychedelics: racial equity in the emerging field of psychedelic-assisted mental health research and treatment J Thrul, A Garcia-Romeu Drugs: Education, Prevention and Policy 28 (3), 211-214, 2021 | 46 | 2021 |